Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

Abroad (travel likely)Recruiting

Conditions

Smoldering Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Bailee Daniels) · Bailee.Daniels@hci.utah.edu · 801-587-4699

Study leads

Ghulam Rehman Mohyuddin, MD
Principal Investigator
Huntsman Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

High-risk Smoldering Multiple Myeloma · Smoldering Multiple Myeloma · Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Denver, United States · Boston, United States

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Multiple Myeloma · Multiple Myeloma Progression · Monoclonal Gammopathy of Undetermined Significance (MGUS)

Abroad (travel likely)Recruiting

Charlotte, United States

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance (MGUS) · Smoldering Multiple Myeloma (SMM)

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States · Boston, United States

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

High Risk Smoldering Multiple Myeloma (HR-SMM)

Abroad (travel likely)RecruitingPHASE3

Atlanta, United States · Boston, United States